Scientists say gene editing holds the key to curing a host of intractable diseases, including cystic fibrosis, HIV, cancer, and cataracts, to name a few. Policymakers fear that, if this key fell into the wrong hands, it could open a Pandora’s box of dangers such as eugenics and performance enhancements on demand. Two Penn Integrates Knowledge professors who are experts in the field recently discussed these pressing issues with Dan Loney on Wharton Business Radio.
James W. Effron University Professor John Gearhart, who holds appointments in thePerelman School of Medicine (PSOM) and in the School of Veterinary Medicineand has served as director of Penn’s Institute for Regenerative Medicine, discovered how to isolate and propagate the world’s first human pluripotent stem cells in 1998.
Read the full story here.